Abivax Income Statement (2021-2025) | ABVX

Income Statement Dec2021 Dec2022 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 4.69210.86M-4.93M136.23M-9.43M47.10M-11.84M-61.93M561.89M
Gross Profit 46.16M59.28M
Operating items
Amortization - Deferred Charges -4.59M-7.60M-9.31M-7.07M-6.13M-108.78M
Research & Development -49.28-111.04-38.83M-31.13M-47.54M271.92M-41.34M-43.74M-64.78M
Selling, General & Administrative -7.65-24.10-8.84M-10.55M-8.10M62.25M-8.45M-9.36M-29.81M
Other Operating Expenses -2.15M-2.42M-0.94M11.80M-0.90M-0.76M-2.15M
Operating Expenses -56.93-135.14-49.82M-44.10M-56.57M345.97M-50.69M-53.87M-96.75M
Operating Income -66.11M-137.07M-48.53M-38.04M-55.12M-45.73M-49.65M-52.63M-94.36M
EBIT -66.11M-137.07M-48.53M-38.04M-55.12M-45.73M-49.65M-52.63M-94.36M
Non-operating items
Interest & Investment Income 6.55M3.89M3.77M4.04M1.63M3.96M23.85M
Net income details
EBT -66.11M-137.07M-46.57M-41.75M-60.65M-42.08M-55.09M-54.80M-179.28M
Profit After Tax -61.93-158.96M-46.57M41.75M60.65M-188.33M55.09M54.80M-297.11M
Income from Continuing Operations -66.11M-137.07M-46.57M-41.75M-60.65M-42.08M-55.09M-54.80M-179.28M
Consolidated Net Income -66.11M-137.07M-46.57M-41.75M-60.65M-42.08M-55.09M-54.80M-179.28M
Income towards Parent Company -66.11M-137.07M-46.57M-41.75M-60.65M-42.08M-55.09M-54.80M-179.28M
Net Income towards Common Stockholders -66.11M-137.07M-46.57M-41.75M-60.65M-42.08M-55.09M-54.80M-179.28M
Additional items
EPS (Basic) -1.55-2.18-0.74-0.66-0.96-0.67-0.87-0.86-2.83
EPS (Weighted Average and Diluted) -3.39-2.96-0.68-0.62-0.87-0.62-0.83-0.76-2.10
Shares Outstanding (Weighted Average) 42.55M62.87M62.87M62.93M62.93M62.93M63.35M63.42M63.44M
Shares Outstanding (Diluted Average) 17.68M19.48M46.34M68.35M67.76M69.44M67.37M66.67M71.81M85.28M
EBITDA -66.11M-137.07M-48.53M-38.04M-55.12M-45.73M-49.65M-52.63M-94.36M